Business Description
EOM Pharmaceutical Holdings Inc
NAICS : 541714
SIC : 8731
ISIN : US4525362046
Description
EOM Pharmaceutical Holdings Inc is focused on developing novel immunomodulatory and retinal disease drug agents to address a range of inflammatory, viral, retinal, and other diseases. Its product candidate includes dual-acting broad-spectrum immunomodulator EOM613, which has the potential to treat cancer cachexia and rheumatoid arthritis, and its advanced formulation of EOM147 is being studied to treat serious retinal diseases without the need for intraocular injection.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 54.34 | |||||
| 9-Day RSI | 50.11 | |||||
| 14-Day RSI | 48.07 | |||||
| 6-1 Month Momentum % | -16.43 | |||||
| 12-1 Month Momentum % | -36.84 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -3 | |||||
| EV-to-EBITDA | -3.01 | |||||
| Earnings Yield (Greenblatt) % | -33.33 | |||||
| FCF Yield % | -54.67 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:IMUC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
EOM Pharmaceutical Holdings Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -4.732 | ||
| Beta | 0.56 | ||
| Volatility % | 107.53 | ||
| 14-Day RSI | 48.07 | ||
| 14-Day ATR ($) | 0.050669 | ||
| 20-Day SMA ($) | 0.181661 | ||
| 12-1 Month Momentum % | -36.84 | ||
| 52-Week Range ($) | 0.11 - 0.4 | ||
| Shares Outstanding (Mil) | 113.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
EOM Pharmaceutical Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
EOM Pharmaceutical Holdings Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
EOM Pharmaceutical Holdings Inc Frequently Asked Questions
What is EOM Pharmaceutical Holdings Inc(IMUC)'s stock price today?
The current price of IMUC is $0.18. The 52 week high of IMUC is $0.40 and 52 week low is $0.11.
When is next earnings date of EOM Pharmaceutical Holdings Inc(IMUC)?
The next earnings date of EOM Pharmaceutical Holdings Inc(IMUC) is .
Does EOM Pharmaceutical Holdings Inc(IMUC) pay dividends? If so, how much?
EOM Pharmaceutical Holdings Inc(IMUC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers